Over-expression of ESE-1 mRNA directly correlates with HER2+ expression in human breast cancers, and ESE-1 mRNA over-expression is often detected in human breast ductal carcinoma in situ, an early stage cancer that also over-expresses HER2 [16, 19]. This evidence concerns the gene ERBB2 and cancer.